FEATURESDietary Supplement Use in Gastrointestinal Symptom Management and Effect on Hopelessness Levels in Patients With Irritable Bowel SyndromeErdogan, Zeynep PhD; Kurçer, Mehmet Ali MD, PhDAuthor Information Ahmet Erdoğan Vocatıonal School of Health Services, Bulent Ecevit University, Zonguldak, Turkey (Dr Erdogan); and Faculty of Medicine, Public Health Department, Bulent Ecevit University, Zonguldak, Turkey (Dr Kurçer). Correspondence: Zeynep Erdogan, PhD, Ahmet Erdoğan Vocatıonal School of Health Services, Bulent Ecevit University, Zonguldak, Turkey ([email protected]). The authors thank Bulent Ecevit University, Faculty of Health Sciences, nursing students for their assistance with the study.The authors have disclosed that they have no significant relationships with, or financial interest in, any commercial companies pertaining to this article. Holistic Nursing Practice: May/June 2019 - Volume 33 - Issue 3 - p 155-162 doi: 10.1097/HNP.0000000000000324 Buy Metrics Abstract This study was conducted to determine the dietary supplement (DS) use in gastrointestinal symptom management, and its effect on hopelessness levels in patients with irritable bowel syndrome (IBS). The universe of this cross-sectional study consisted of 132 patients presenting at the polyclinic, while the sample consisted of 127 patients who meet the inclusion criteria to study. Data were collected using a patient identification form including sociodemographic characteristics and DS use, the Gastrointestinal Symptom Rating Scale, and the Beck Hopelessness Scale. The frequency of DS use in the last year among patients with IBS was 73.2%. Younger, women, those with graduate education, and those with better economic status were found to prefer more DS (P < .0001). Nausea and decreased passage of stools were predictors of DS use with a rate of 40.9% (R2 = 0.409, P < .0001). The patients were found to use mint oil (35.6%), mint juice (24.6%), lemon (20.5%) for nausea, and apricots (48.2%) and dietary fibers (16.9%) for decreased passage of stools. Patients who did not use DSs were found to be more hopeless (P < .03). It was found that 73.2% of patients with IBS used DSs. Patients who did not use DSs were found to be more hopeless. DSs with proven effectiveness can be integrated into medical treatments. © 2019 Wolters Kluwer Health, Inc. All rights reserved.